Thermo Fisher Announce Owlstone Medical Collaboration
Thermo Fisher Scientific has announced a collaboration with Owlstone Medical to advance the early diagnosis of cancer and other diseases utilizing novel biomarkers and non-invasive breath sampling.
Thermo Fisher Scientific has announced a collaboration with Owlstone Medical to advance the early diagnosis of cancer and other diseases utilizing novel biomarkers and non-invasive breath sampling.
“There is a growing need for non-invasive diagnostic solutions to support early disease detection, patient treatment and increase remission rates,” said Morten Bern, director of marketing, gas chromatography, Thermo Fisher Scientific.
The collaboration will see Orbitrap gas chromatography–mass spectrometry (GC–MS) instrumentation integrated with Owlstone Medical’s Breath Biopsy platform allowing the detection of new biomarkers via a validated discovery and routine analysis project.
“With an installed base of GC Orbitrap systems, our collaboration with Thermo Fisher Scientific represents an exciting opportunity for cross-promotion of the platform and technique, by which the benefits of breath biopsy can be broadly realized,” said Billy Boyle, co-founder and chief executive officer at Owlstone Medical.
For more information, please visit: www.thermofisher.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
